SR-9009 (Stenabolic)
es-ar-nine-zero-zero-nine
Category
Compound type
Phase / Status
Preclinical research only; human clinical trials and established dosing/safety are not available. Not an approved drug.
Standard Dose
3x daily (oral) or 2x daily (SubQ)
Half-life
Plasma elimination
Route(s)
Oral
Research Stage
Animal/in-vitro data only; no human trial evidence.
Overview
SR-9009 targets Rev-ErbA proteins that help regulate the internal timing system and metabolism. In animal and cell studies, this has been linked to changes in mitochondrial biology and energy-related pathways. Human safety and effectiveness are not established.
Plain-language summary
SR-9009 targets Rev-ErbA proteins that help regulate the internal timing system and metabolism. In animal and cell studies, this has been linked to changes in mitochondrial biology and energy-related pathways. Human safety and effectiveness are not established.
Administration Routes
- Oral
Also known as
Mechanisms
Rev-ErbA agonist — modulates circadian rhythm signaling and may increase mitochondrial biogenesis and metabolic activity.
Detailed mechanism
Rev-ErbA agonist - modulates circadian rhythm proteins to increase mitochondrial biogenesis and metabolic rate. Modulates cellular pathways and enzyme activity to produce therapeutic effects at the molecular level.
Safety
Side effects
- Limited human safety data
- Potential effects on sleep/circadian timing
- Formulation and absorption can vary widely by route and product quality
- Injection-related adverse events can occur if products are administered by injection
Reported benefits
- Increased metabolic rate at rest
- Improved endurance and stamina
- Enhanced fat burning 24/7
- Better sleep pattern regulation
- Reduced inflammation
- No hormonal suppression
Safety profile
Human safety and efficacy are not established. If considering any investigational compound, consult qualified medical professionals and avoid self-experimentation.
Clinical trials
Evidence is limited to preclinical studies in animal/cell models; no established clinical trial results in humans.
Structure
Verified structure
SR-9009 (Stenabolic)
Exact 2D structure can be rendered from a PubChem-backed canonical SMILES string.
- Chemical Formula
- C20H24ClN3O4S
- Molecular Weight
- 437.94 g/mol
- CAS Number
- 1379686-30-2
- InChIKey
- MMJJNHOIVCGAAP-UHFFFAOYSA-N
Stack Context
Stacks with
References
- 1View source
Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists (Nature)
2012
- 2View source
Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy (Nature Medicine)
2013
- 3View source
Circadian integration of metabolism and energetics (Science)
2010
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.